Posts in category Short Ideas


Bristol Myers Squibb (BMY) Will Face Significant Headwinds in 2019; Here’s Why

Yesterday, Merck (NYSE:MRK) reported data from Keytruda in combo with chemotherapy for patients with non-small …

Analyst Raises Red Flags on Intel (INTC) Ahead of 1Q18 Earnings

Rosenblatt’s Hans Mosesmman offers a slew of reasons he continues to bet against INTC ahead of its quarterly print.

Downgrading Facebook (FB) to Sell

It’s been a rough few weeks for social media giant Facebook (NASDAQ:FB). As we discussed just …

Tesla (TSLA): Goldman Sachs Just Got More Bearish on Model 3 Production Track

Goldman Sachs’ analyst David Tamberrino now looks for a sharp 36% downside for Tesla shares.

Tesla Inc (TSLA): Is It Time for Bulls to Give Up the Fight?

Expert voices across the Street point to warning flags mounting around the TSLA narrative; here’s why.

Shopify Should Trade Back to $100 on Back of Facebook Risk: Citron

Shopify (NYSE:SHOP) and Facebook (NASDAQ:FB) have been in an unholy alliance for years – in which …

AbbVie Inc (ABBV) Has More Than Just a Terrible Setback for Rova-T to Confront; Bear Warns Further Downside Risk Lies Ahead

Alex Arfaei notes he continues to be the “lone bear” on this biotech player- especially after lead pipeline asset Rova-T is no longer looking at quick approval.

This Analyst Sounds the Alarm on MannKind Corporation (MNKD)

What do you do when a company has “more debt than assets?” Maxim’s Jason Kolbert just lost patience with MNKD.

Square Inc (SQ): A Story of Overbaked Hope and Uncertainty?

BTIG’s Mark Palmer likewise is not swayed by the Bitcoin craze, believing investors are “overly” confident in its impact on SQ stock.